Prediction of overall survival through circadian rest-activity monitoring during chemotherapy for metastatic colorectal cancer

Circadian robustness as an independent predictor of prolonged progression-free survival (PFS) and overall survival (OS) in 436 patients with metastatic colorectal cancer (mCRC).

(2017) Francis Levi et al.   JOURNAL OF CLINICAL ONCOLOGY

Breast Cancer Patients have Progressively Impaired Sleep-Wake Activity Rhythms during Chemotherapy

(2017) Josée Savard et al.   SLEEP

Sex and Dosing-Time Dependencies in Irinotecan-Induced Circadian Disruption

(2011) Constance Ahowesso et al.   CHRONOBIOLOGY INTERNATIONAL

Definition and classification of cancer cachexia: an international consensus

(2011) Kenneth Fearon et al.   LANCET ONCOLOGY

Sex difference in the near-24-hour intrinsic period of the human circadian timing system

(2011) J. F. Duffy et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Chronotherapy and the molecular clock: Clinical implications in oncology☆

(2010) Pasquale F. Innominato et al.   ADVANCED DRUG DELIVERY REVIEWS

Circadian Timing in Cancer Treatments

(2010) Francis Lévi et al.   Annual Review of Pharmacology and Toxicology

Cancer Inhibition through Circadian Reprogramming of Tumor Transcriptome with Meal Timing

(2010) X. M. Li et al.   CANCER RESEARCH

Recent trends in colorectal cancer mortality in Europe

(2010) Cristina Bosetti et al.   INTERNATIONAL JOURNAL OF CANCER

Sex Differences in Phase Angle of Entrainment and Melatonin Amplitude in Humans

(2010) Sean W. Cain et al.   JOURNAL OF BIOLOGICAL RHYTHMS

A New Integrated Variable Based on Thermometry, Actimetry and Body Position (TAP) to Evaluate Circadian System Status in Humans

(2010) Elisabet Ortiz-Tudela et al.   PLoS Computational Biology

Circadian Rhythm in Rest and Activity: A Biological Correlate of Quality of Life and a Predictor of Survival in Patients with Metastatic Colorectal Cancer

(2009) P. F. Innominato et al.   CANCER RESEARCH

Circadian Clock Manipulation for Cancer Prevention and Control and the Relief of Cancer Symptoms

(2009) William J. M. Hrushesky et al.   INTEGRATIVE CANCER THERAPIES

Circadian Disruption, Fatigue, and Anorexia Clustering in Advanced Cancer Patients: Implications for Innovative Therapeutic Approaches

(2009) Pasquale F. Innominato et al.   INTEGRATIVE CANCER THERAPIES

Toxic effects and their management: daily clinical challenges in the treatment of colorectal cancer

(2009) Cathy Eng   Nature Reviews Clinical Oncology

Symptom clusters in patients with advanced cancers

(2009) Winson Y. Cheung et al.   SUPPORTIVE CARE IN CANCER

Patterns of circadian activity rhythms and their relationships with fatigue and anxiety/depression in women treated with breast cancer adjuvant chemotherapy

(2009) Ann M. Berger et al.   SUPPORTIVE CARE IN CANCER

Neuroendocrine-Immune Mechanisms of Behavioral Comorbidities in Patients With Cancer

(2008) Andrew H. Miller et al.   JOURNAL OF CLINICAL ONCOLOGY

Methodological Challenges When Using Actigraphy in Research

(2008) Ann M. Berger et al.   JOURNAL OF PAIN AND SYMPTOM MANAGEMENT

A Systematic Review and Meta-Analysis of the Pharmacological Treatment of Cancer-Related Fatigue

(2008) O. Minton et al.   JNCI-Journal of the National Cancer Institute

Molecular epidemiology, cancer-related symptoms, and cytokines pathway

(2008) Cielito C Reyes-Gibby et al.   LANCET ONCOLOGY

Application of distance matrices to define associations between acute toxicities in colorectal cancer patients receiving chemotherapy

(2007) Giuseppe Aprile et al.   CANCER

From inflammation to sickness and depression: when the immune system subjugates the brain

(2007) Robert Dantzer et al.   NATURE REVIEWS NEUROSCIENCE